» Articles » PMID: 23100345

Molecular Characterization of a Respiratory Syncytial Virus Outbreak in a Hematology Unit in Heidelberg, Germany

Abstract

In 2011 and 2012, a large outbreak of respiratory syncytial virus (RSV) infections affecting 57 laboratory-confirmed patients occurred in an adult hematology unit in Heidelberg, Germany. During the outbreak investigation, we performed molecular genotyping of RSV strains to differentiate between single versus multiple introductions of the virus into the unit. Furthermore, we assessed the time of viral shedding of consecutive samples from the patients in order to better understand the possible impact of prolonged shedding for outbreak control management. We used subtype-specific reverse transcription-PCR on nasopharyngeal and bronchoalveolar specimens for routine diagnostics and for measuring the viral shedding period. Samples of 47 RSV-infected patients involved in the outbreak were genotyped by sequence analysis and compared to samples from RSV-infected hospitalized children representing the timing of the annual RSV epidemic in the community. Molecular investigation of the virus strains from clinical samples revealed a unique cluster with identical nucleotide sequences of RSV type A (RSV A outbreak strain) for 41 patients, while 3 patients were infected with different RSV A (nonoutbreak) strains and three other patients with RSV type B. Outbreak strains were identified in samples from November 2011 until January 2012, while nonoutbreak strains were from samples coinciding with the community epidemic in February and March 2012. Median duration of viral shedding time was 24.5 days (range, 1 to 168 days) with no difference between outbreak and nonoutbreak strains (P = 0.45). Our investigation suggests a single introduction of the RSV A outbreak strain into the unit that spread among the immunocompromised patients. Prolonged viral shedding may have contributed to nosocomial transmission and should be taken into account in the infection control management of RSV outbreaks in settings with heavily immunosuppressed patients.

Citing Articles

Risk of nosocomial respiratory syncytial virus versus influenza among adult patients in acute care hospitals.

Auvinen R, Huotari K, Nohynek H, Syrjanen R, Skogberg K Infect Prev Pract. 2025; 7(1):100431.

PMID: 39896063 PMC: 11782808. DOI: 10.1016/j.infpip.2024.100431.


Approach to hematopoietic cell transplant candidates with respiratory viral detection.

Kim S, Waghmare A, Hijano D Front Pediatr. 2024; 11:1339239.

PMID: 38304442 PMC: 10830789. DOI: 10.3389/fped.2023.1339239.


Infection prevention requirements for the medical care of immunosuppressed patients: recommendations of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute.

GMS Hyg Infect Control. 2022; 17:Doc07.

PMID: 35707229 PMC: 9174886. DOI: 10.3205/dgkh000410.


Evaluation of the Roche antigen rapid test and a cell culture-based assay compared to rRT- PCR for the detection of SARS-CoV-2: A contribution to the discussion about SARS-CoV-2 diagnostic tests and contagiousness.

Steinlin-Schopfer J, Barbani M, Kamgang R, Zwahlen M, Suter-Riniker F, Dijkman R J Clin Virol Plus. 2022; 1(1):100020.

PMID: 35262007 PMC: 8106823. DOI: 10.1016/j.jcvp.2021.100020.


Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Goubet A, Dubuisson A, Geraud A, Danlos F, Terrisse S, Alves Costa Silva C Cell Death Differ. 2021; 28(12):3297-3315.

PMID: 34230615 PMC: 8259103. DOI: 10.1038/s41418-021-00817-9.


References
1.
Shah J, Chemaly R . Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood. 2010; 117(10):2755-63. DOI: 10.1182/blood-2010-08-263400. View

2.
Brandenburg A, Van Beek R, Moll H, Osterhaus A, Claas E . G protein variation in respiratory syncytial virus group A does not correlate with clinical severity. J Clin Microbiol. 2000; 38(10):3849-52. PMC: 87491. DOI: 10.1128/JCM.38.10.3849-3852.2000. View

3.
Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J . Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009; 15(10):1143-238. PMC: 3103296. DOI: 10.1016/j.bbmt.2009.06.019. View

4.
Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S . MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011; 28(10):2731-9. PMC: 3203626. DOI: 10.1093/molbev/msr121. View

5.
Sullender W, MUFSON M, Prince G, Anderson L, Wertz G . Antigenic and genetic diversity among the attachment proteins of group A respiratory syncytial viruses that have caused repeat infections in children. J Infect Dis. 1998; 178(4):925-32. DOI: 10.1086/515697. View